Prevalence of pilus-encoding islets among acute otitis media Streptococcus pneumoniae isolates from Israel  by Moschioni, M. et al.
Prevalence of pilus-encoding islets among
acute otitis media Streptococcus
pneumoniae isolates from Israel
M. Moschioni1, G. De Angelis1, S. Melchiorre1,
V. Masignani1, E. Leibovitz2, M. A. Barocchi1
and R. Dagan2,3
1) Novartis Vaccines and Diagnostics s.r.l., Research Center, Siena, Italy,
2) Faculty of Health Sciences, Ben-Gurion University of the Negev and
3) Pediatric Infectious Disease Unit, Soroka University Medical Center,
Beer-Sheva, Israel
Abstract
We evaluated the distribution of the two known Streptococcus
pneumoniae pilus encoding islets (PI-1 and PI-2) among a panel of
113 acute otitis media clinical isolates from Israel. PI-1 was present
in 30.1% (n = 34) of the isolates tested, and PI-2 was present in
7% (n = 8). In addition, we found that: (i) the PI positive isolates,
50% of which belong to the international clones Spain9V-3 (ST156)
and Taiwan19F-14 (ST236), correlate with the genotype (as deter-
mined by multilocus sequence typing) but not with the serotype;
(ii) PI-2 was not present in the absence of Pl-1; and (iii) the
frequency of PI-1 was higher among antibiotic-resistant isolates.
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The human pathogen Streptococcus pneumoniae is commonly
associated with invasive diseases such as meningitis and
sepsis. In addition, pneumococci are the most frequent cause
of upper respiratory infections such as sinusitis and acute
otitis media (AOM), which is one of the most widespread
childhood infections and a major cause of morbidity in chil-
dren [1,2]. Hence, it is important to investigate the presence
of pathogenic factors that may be responsible for disease
outcome among AOM clinical isolates.
Recently, genetic analysis of S. pneumoniae clinical isolates
demonstrated that they harbour pilus structures encoded by
the rlrA pathogenicity islet (pilus islet-1, PI-1) and the pilus
islet-2 (PI-2). The PI-1 pilus was shown to be involved in
virulence [3,4] and antibodies raised against its protein
subunits were protective in a murine model of infection [5].
However, the islets are not widely distributed in S. pneumo-
niae. Three independent studies demonstrated that, in both
invasive and nasopharyngeal clinical isolates, the frequency
of the PI-1 islet is approximately 30% [6–8], although the
incidence was higher among antibiotic-resistant clones [8].
This suggests that the interplay between the pilus (encoded
by PI-1) and antibiotic resistance may facilitate the global
spread of antibiotic nonsusceptible pneumococci [9]. A
recent study demonstrated that PI-2 is present in approxi-
mately 16% of invasive and nasopharyngeal clinical isolates
[10], and that both islets are present in the Taiwan19F-14
(ST236) clone, whose spread is responsible for the increas-
ing incidence of antibiotic-resistant isolates in many coun-
tries [11–13].
Therefore, to evaluate a possible correlation between
AOM and the presence of PIs, we aimed to assess the preva-
lence of the pilus encoding islets in a collection of AOM clin-
ical isolates, for which no data are available thus far.
A total of 113 pneumococcal isolates were obtained from
the middle ear ﬂuid of 113 patients with AOM presenting at
the Soroka University Medical Center Pediatric Emergency
Department, from 1 January 2007 to 29 March 2007. The
patients were Jewish children (n = 55) and Bedouin children
(n = 58) who did not receive the heptavalent conjugate
pneumococcal vaccine (PCV7) because PCV 7 vaccination
was not implemented in Israel at the time of the study. The
age of the children was in the range 0.8–96.9 months
(mean ± SD 13.3 ± 15.5 months; median 9.7 months). Of
the 113 isolates, 85 (75%) were obtained by tympanocentesis
and 17 (15%) were from spontaneous drainage; it was not
clear whether the remaining 11 isolates (10%) were obtained
from tympanocentesis or spontaneous drainage. Of 107 iso-
lates from which information about antibiotic treatment of
the patient in the month prior to culture was available, 32
(30%) were from children receiving antibiotics in previous
months. S. pneumoniae was isolated as a single pathogen in
62/113 (65%) cases; in 46 (41%) together with Haemophilus
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inﬂuenzae; and in ﬁve (4%) together with other combinations
of pathogens. Identiﬁcation, serotyping and antimicrobial
susceptibility testing was performed as described previously
[14].
The most commonly isolated serotype was serotype 14,
followed by 19F, 23F, 19A, 6B and 18C (Fig. 1a). All isolates
were tested for the presence of PI-1 and PI-2 by PCR using
a speciﬁc set of primers as described previously [8,10].
Ampliﬁcations to determine the genomic location and the
presence of islets were performed directly from bacterial
colonies grown overnight on blood-agar plates.
Of 113 isolates, 34 (30.1%) were positive for S. pneumo-
niae PI-1 and eight (7%) were positive for PI-2; PI-1 was
found in serotypes 6A, 6B, 14, 19F, 23F, 33A and 11A,
(Fig. 1a). On the other hand, PI-2 was only found in serotype
19F isolates and always associated with PI-1 (Fig. 1a). Subse-
quently, the isolates containing PI-1 or both PI-1 and PI-2
were typed by multilocus sequence typing [15] and grouped
by E-BURST analysis (http://eburst.mlst.net/) by clonal com-
plex (CC) (Fig. 1b), revealing that they belonged to CCs
already reported to be most likely to carry the PI-1 [6–8].
Isolates that harboured both pilus islets were mainly of the
CC271, single or double locus variants of the international
clone Taiwan19F-14. Among the isolates containing only PI-1,
CC156 was the prevalent clone (international clone Spain9V-3).
Interestingly, out of 12 CC156 isolates, 11 (92%) were sero-
type 14, conﬁrming the increasing association of this sero-
type with clone CC156 [9].
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FIG. 1. Acute otitis media (AOM) isolates collection characterized for the presence of pilus islet (PI)-1 and PI-2. (a) Collection of AOM isolates
stratiﬁed by serotype and analysed for the presence of PI-1 and PI-2. *Serotypes with two isolates only (3, 4, 8, 15B, 16F, 18A, 33A) or one iso-
late only (7B, 9N, 9V, 11A, 23A, 23B, 24F, 31, 33F, 35B, not typable). PI-1 was present only in one of the two serotype 33A isolates and in the
11A isolate. (b) PI-1 and PI-2 positive isolates stratiﬁed by clonal complex (CC), determined by E-BURST grouping, after multilocus sequence
typing. The serotypes to which the CCs are associated are shown with different colours. CCs have been named according to the sequence
typing number of the E-BURST predicted founder. S, singletons. *Serotype 19F isolates positive for both PI-1 and PI-2.
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No correlation was found with age or gender of the chil-
dren, whereas the percentage of PI positive isolates among
the Jewish population was higher (43.6%) compared with
to Bedouins (17.2%), although the proportion of antibiotic
resistant clones was comparable in the two groups. More-
over, children who had experienced one or more otitis
media episodes in the previous year were more likely to be
infected with S. pneumoniae carrying the pilus-encoding islets
than children who had not (46% vs. 18%; p 0.002). The con-
comitant presence of H. inﬂuenzae in the infection site did
not correlate with PIs positive S. pneumoniae (28%).
Because PI-1 was found mainly in serotypes with prevalent
antibiotic resistance, we analysed its presence or absence by
the antibiotic-resistance pattern in each of the serotypes in
which it was described (Table 1). The percentage of PI-1
positive isolates among antibiotic-resistant strains reached
41.5% in penicillin-nonsusceptible isolates (MIC >0.1 mg/L),
51.8% among multidrug-resistant isolates, and 51.6% in eryth-
romycin- resistant isolates. By contrast, the proportion of
PI-1 strains in strains susceptible to all tested antibiotics was
5.7% (p 0.001). These ﬁndings conﬁrm the previously found
association between piliated S. pneumoniae and antibiotic
resistance [8].
In conclusion, the data obtained in the present study indi-
cate that the incidence of piliated pneumococci in otitis
media isolates is not greater than in other invasive disease
isolates and that the pilus does not appear to confer an addi-
tional selective beneﬁt in the middle ear during otitis media.
A limitation of the present study is the small sample size of
clinical isolates tested. However, the results obtained con-
ﬁrm the correlation of PI in S. pneumoniae with genotype and
antibiotic resistance. Further studies are needed to under-
stand the epidemiological relevance of the pilus and its role
in disease outcome. Although vaccination with PCV7
reduced the frequency of persistent and recurrent AOM
[16], multidrug-resistant nonvaccine serotypes such as sero-
type 19A are increasing, associated with CC156 [17]. This
clone was a prevalent clone in the present study. Therefore,
the elucidation of the pathogenesis of AOM may help
advance the development of a serotype-independent pneu-
mococcal vaccine for otitis media, and a new generation pro-
tein vaccine that includes pilus subunits could reduce otitis
media disease.
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Modiﬁed sequential multiplex PCR for
determining capsular serotypes of invasive
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Abstract
The heptavalent pneumococcal vaccine’s introduction resulted in
a decline in invasive disease caused by Streptococcus pneumoniae,
but was accompanied by an increase in non-vaccine serotypes.
We evaluated a modiﬁed scheme of the sequential multiplex
PCRs adapted to the prevalence of serotypes in Seville (Spain)
for determining capsular serotypes of S. pneumoniae invasive clin-
ical isolates. In adults, the modiﬁed scheme allowed us to type
73% with the ﬁrst three reactions, and 92% with two additional
PCRs. In paediatric patients, it allowed us to type 73.5% with
the ﬁrst three reactions, and 90% with the two additional PCRs.
The multiplex PCR approach was successfully adapted to target
the serotypes most prevalent in Seville.
Keywords: Capsular polysaccharide, invasive infection, multiplex
PCR, serotype, Streptococcus pneumoniae
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Streptococcus pneumoniae causes severe illnesses in the
elderly and children. The immunochemistry of the capsular
polysaccharide differentiates pneumococci into 91 distinct
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